Key Metrics Comparison:
NPV (Net Present Value):
- Pre-tax: US$673m (A$1,040m)
- Post-tax: US$502m (A$776m)
These values confirm the strong financial returns of the project, as discussed earlier.IRR (Internal Rate of Return):
- Pre-tax: 52.2%
- Post-tax: 43.6%
These IRR figures are exceptional and validate the project's attractiveness to investors, as highlighted in the initial analysis.Capex (Capital Expenditure):
- US$108.7m (A$168.1m)
The capital expenditure required is relatively modest compared to the project's long-term revenue and profitability, supporting the conclusion of a short payback period of 2.4 years.Revenue and EBITDA:
- Net Revenue: US$2,116m (A$3,274m)
- EBITDA: US$1,782m (A$2,756m)
These figures align with the original summary and underscore the substantial profit potential of the facility over its 20-year lifespan.OPEX (Operating Expenses):
- OPEX per kg of REO (excluding magnet costs): US$27.68 (A$42.82)
This low operating cost reinforces the project's high margins and profitability.Exchange Rates:
- The exchange rate assumptions (1 GBP = 1.28 US$, 1 A$ = 0.65 US$) are reasonable and consistent with international standards, validating the financial conversions used in both the original and updated analyses.
Additional Insights:
Pre-Tax vs. Post-Tax Metrics:
Including pre-tax values (NPV and IRR) in this table provides a clearer picture of the project's profitability before government taxation effects. This does not alter the overall assessment but emphasizes the project's robustness even after tax considerations.OPEX Detail:
The OPEX per kg REO (excluding magnets) provides a more precise understanding of the cost structure, highlighting the project's competitive operational efficiency.
- Forums
- ASX - By Stock
- IXR
- Ann: FS DEMONSTRATES PROFITABLE MAGNET REO BUSINESS CASE
IXR
ionic rare earths limited
Add to My Watchlist
20.0%
!
1.2¢

Ann: FS DEMONSTRATES PROFITABLE MAGNET REO BUSINESS CASE, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.2¢ |
Change
0.002(20.0%) |
Mkt cap ! $63.20M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $145.5K | 12.20M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 4930184 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 8157196 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 4630184 | 0.011 |
43 | 27026805 | 0.010 |
22 | 15815440 | 0.009 |
22 | 18836661 | 0.008 |
38 | 17744022 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 7757196 | 12 |
0.014 | 9849627 | 14 |
0.015 | 5392525 | 7 |
0.016 | 3379515 | 5 |
0.017 | 3090509 | 6 |
Last trade - 15.58pm 27/06/2025 (20 minute delay) ? |
Featured News
IXR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online